MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ: MIRA · Real-Time Price · USD
1.160
0.00 (0.00%)
At close: Mar 9, 2026, 4:00 PM EDT
1.200
+0.040 (3.45%)
After-hours: Mar 9, 2026, 6:55 PM EDT
MIRA Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 5.02 | 4.71 | 6.95 | 4.7 | 1.47 | 0.16 |
| Research & Development | 2.08 | 3.31 | 1.57 | 2.35 | 0.68 | 0.04 |
| Operating Expenses | 7.11 | 8.02 | 8.53 | 7.05 | 2.15 | 0.2 |
| Operating Income | -7.11 | -8.02 | -8.53 | -7.05 | -2.15 | -0.2 |
| Interest Expense | - | - | -3.46 | -0.01 | -0.02 | -0 |
| Interest & Investment Income | 0.08 | 0.17 | - | - | - | - |
| Pretax Income | -6.86 | -7.85 | -11.98 | -7.06 | -2.18 | -0.2 |
| Net Income | -6.86 | -7.85 | -11.98 | -7.06 | -2.18 | -0.2 |
| Net Income to Common | -28.42 | -7.85 | -11.98 | -7.06 | -2.18 | -0.2 |
| Shares Outstanding (Basic) | 18 | 15 | 14 | 18 | 13 | - |
| Shares Outstanding (Diluted) | 18 | 15 | 14 | 18 | 13 | - |
| Shares Change (YoY) | 17.53% | 10.91% | -20.73% | 38.60% | - | - |
| EPS (Basic) | -1.61 | -0.51 | -0.86 | -0.40 | -0.17 | - |
| EPS (Diluted) | -1.61 | -0.51 | -0.86 | -0.40 | -0.17 | - |
| EBIT | -7.11 | -8.02 | -8.53 | -7.05 | -2.15 | -0.2 |
Source: S&P Capital IQ. Standard template.
Financial Sources.